Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 11/20 | 0.59 |
| ▸ | CHRNA4 | P43681 | 11/20 | 0.59 |
| ▸ | CHRNB4 | P30926 | 9/20 | 0.59 |
| ▸ | CHRNA3 | P32297 | 7/20 | 0.42 |
| ▸ | ANPEP | P15144 | 2/20 | 0.35 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.35 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL8583071 | 0.88 | CHRNB2 (0.46) | CHRNB2CHRNA4CHRNB4CHRNA3TGFBR1 | |
| SCHEMBL11283812 | 0.86 | CHRNB2 (0.45) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL28191169 | 0.83 | CHRNB2 (0.39) | CHRNB2CHRNA4CHRNB4CHRNA3ANPEP | |
| SCHEMBL6845595 | 0.82 | CHRNB2 (0.40) | CHRNB2CHRNA4CHRNB4CHRNA3ANPEP | |
| SCHEMBL3169477 | 0.81 | CHRNB2 (0.38) | CHRNB2CHRNA4CHRNB4ANPEPRNPEP | |
| SCHEMBL1147853 | 0.81 | CHRNB2 (0.40) | CHRNB2CHRNA4CHRNB4CHRNA3TGFBR1 | |
| SCHEMBL3235398 | 0.80 | ANPEP (0.52) | ANPEPRNPEPDNPEPTGFBR1RAB9A | |
| SCHEMBL27851633 | 0.80 | CHRNB2 (0.37) | CHRNB2CHRNA4CHRNB4ANPEPRNPEP | |
| SCHEMBL3736026 | 0.79 | ANPEP (0.37) | CHRNB2CHRNA4CHRNB4ANPEPRNPEP | |
| SCHEMBL157717 | 0.79 | ALDH1A1 (0.45) | CHRNB2CHRNA4CHRNB4ANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017012963-A1 | POLYMERIZABLE FATTY ACID-DERIVATIVE-MONOMERS WITH TERMINAL OLEFINIC DOUBLE BONDS, POLYMERS CONTAINING SAME MONOMERS, PRODUCTION AND USE THEREOF | BASF SE (DE) | 2017-01-26 | — | — | WO | claimed |
| WO-2007126775-A2 | COMPOSITIONS AND METHODS FOR MAKING AND USING ACYCLIC N-HALAMINE-BASED BIOCIDAL POLYMERIC MATERIALS AND ARTICLES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-11-08 | — | — | WO | claimed |
| US-20070224161-A1 | Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-09-27 | — | — | US | claimed |
| EP-1490016-B1 | CATIONIC POLYMERS AND THE USE THEREOF IN COSMETIC FORMULATIONS | BASF AG (DE) | 2007-06-06 | — | — | EP | claimed |
| US-20050084469-A1 | Cationic polymers and the use thereof in cosmetic formulations | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-21 | — | — | US | claimed |
| EP-1490016-A1 | CATIONIC POLYMERS AND THE USE THEREOF IN COSMETIC FORMULATIONS | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-29 | — | — | EP | claimed |
| WO-2003106522-A1 | POLYOXYALKYLENE-SUBSTITUTED ALKYLENE DIAMINES AND THE USE THEREOF IN COSMETIC FORMULATIONS | BASF AKTIENGESELLSCHAFT (DE) | 2003-12-24 | — | — | WO | claimed |
| WO-2003080001-A1 | CATIONIC POLYMERS AND THE USE THEREOF IN COSMETIC FORMULATIONS | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-02 | — | — | WO | claimed |
| US-12100860-B2 | Separator for electrochemical device and an electrochemical device comprising the same | LG ENERGY SOLUTION, LTD. (KR) | 2024-09-24 | — | — | US | disclosed |
| EP-4355798-A1 | BIODEGRADABLE GRAFT POLYMERS | BASF SE (DE) | 2024-04-24 | — | — | EP | disclosed |
| CN-112640196-B | Separator for electrochemical device and electrochemical device including the same | 株式会社LG新能源 | 2024-02-09 | — | — | CN | disclosed |
| WO-2022263354-A1 | BIODEGRADABLE GRAFT POLYMERS | BASF SE (DE) | 2022-12-22 | — | — | WO | disclosed |
| US-20220006156-A1 | A SEPARATOR FOR ELECTROCHEMICAL DEVICE AND AN ELECTROCHEMICAL DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2022-01-06 | — | — | US | disclosed |
| EP-3916836-A1 | SEPARATOR FOR ELECTROCHEMICAL DEVICE, AND ELECTROCHEMICAL DEVICE COMPRISING SAME | LG ENERGY SOLUTION, LTD. (KR) | 2021-12-01 | — | — | EP | disclosed |
| EP-1000610-A1 | Polymers for cosmetic formulations | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-17 | — | — | EP | disclosed |
| EP-0998254-A2 | USE OF POLYMERS CONTAINING POLYSILOXANE FOR COSMETIC FORMULATIONS | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-10 | — | — | EP | disclosed |
| WO-2000005274-A1 | METHOD FOR PRODUCING POWDER-SHAPED CROSS-LINKED POLYMERIZATES | BASF AKTIENGESELLSCHAFT (DE) | 2000-02-03 | — | — | WO | disclosed |
| CN-1209991-A | High molecular mass cationic copolymers | BASF AG (DE) | 1999-03-10 | — | — | CN | disclosed |
| WO-1999004750-A2 | USE OF POLYMERS CONTAINING POLYSILOXANE FOR COSMETIC FORMULATIONS | BASF AKTIENGESELLSCHAFT (DE) | 1999-02-04 | — | — | WO | disclosed |
| EP-0893117-A2 | Cationic copolymers of high molecular weight | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070224161-A1 | Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles | NAAA, NIT2, AADAC | CHRNB2 1967/4885CHRNA4 2206/4885CHRNB4 1934/4885 |
| US-20050084469-A1 | Cationic polymers and the use thereof in cosmetic formulations | PARN, CUTA, PARG | CHRNB2 4367/4885CHRNA4 4390/4885CHRNB4 4119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.